ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
RXi and Karolinska Institutet target solid tumour therapy
pharmaceutical-technology
August 17, 2018US-based biotechnology company RXi Pharmaceuticals has formed a research alliance with the Karolinska Institutet in Stockholm, Sweden, to develop and improve immuno-oncology treatments for solid tumours. -
Developing nanopreparation properties for use in anticancer medicines
europeanpharmaceuticalreview
March 16, 2017Tumour therapy, particularly in the case of multidrug resistant cancers, could be significantly enhanced by using siRNA to down-regulate the production of proteins involved in cancer cell resistance such as Pgp or survivin...
Pharma Sources Insight July 2025
